{"id":"W4408555362","doi":"10.1055/s-0045-1804605","title":"Baseline characteristics of patients enrolled in FIBRONEER(TM)-IPF, a Phase III randomised placebo-controlled trial of the preferential PDE4B inhibitor BI 1015550 in patients with idiopathic pulmonary fibrosis","year":2025,"lang":"en","type":"article","venue":"Pneumologie","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Medicine; Placebo; Idiopathic pulmonary fibrosis; Internal medicine; Gastroenterology; Lung; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007325267,0.000416721,0.001850034,0.0004593041,0.00006485917,0.00001475995,0.0003241996,0.0002771434,0.00006063805],"category_scores_gemma":[0.001485124,0.0002717736,0.0004711736,0.0006252133,0.0002522807,0.0001233343,0.0001974964,0.0004364077,0.000001819758],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001924433,"about_ca_system_score_gemma":0.000526989,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006708022,"about_ca_topic_score_gemma":0.000008273454,"domain_scores_codex":[0.996047,0.0005888462,0.001788791,0.00050955,0.0006085593,0.0004572225],"domain_scores_gemma":[0.9978498,0.0003509078,0.0007039023,0.0006019266,0.0003833841,0.0001100983],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9288356,0.007653897,0.05757578,0.0005858726,0.0001541158,0.00002002007,0.00009685966,0.0000159453,0.003681348,0.00001475173,0.00003584912,0.001329916],"study_design_scores_gemma":[0.8667899,0.008529865,0.1192073,0.00237676,0.0005405257,8.247438e-7,0.0000418029,0.00079115,0.001409421,0.00003370108,0.00002364112,0.0002550826],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.990933,0.0001547976,0.00004151922,0.0001715299,0.0007711484,0.007206299,0.0002612833,0.00002888256,0.0004315539],"genre_scores_gemma":[0.9988031,0.00003607977,0.00002435275,0.00007717502,0.0001160699,0.0005383531,0.0002056774,0.00003090471,0.0001683095],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06204569,"threshold_uncertainty_score":0.9999734,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006961559503105179,"score_gpt":0.2415424038703154,"score_spread":0.2345808443672103,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}